肺癌

For small-cell lung cancer, Western medicine is mainly used chemotherapy treatment to chemotherapy mainly with the application of radiation therapy; TCM syndrome differentiation treatment of the disease Zeyi mainly carried out more than with chemotherapy, there are some used in the unilateral disease, prescription.
TCM treatment of small cell lung cancer
Chinese medicine treatment of small cell lung cancer mainly Chinese and Western medicine with the main, most of them with chemotherapy or radiation therapy so as to eliminate chemotherapy, radiotherapy side effects, more common, only a few are directly aimed at the treatment of lung cancer itself, traditional Chinese medicine combined with chemotherapy, radiotherapy is a clinically verified an effective manner.
Small-cell lung cancer therapy
Generally considered that all by histology, cytology or clinical diagnosis of lung cancer patients, as long as the stage of disease at the stage Ⅱ ago, and no absolute contraindications, surgery can be classified as to adapt to the object. However, a high degree of malignant small cell carcinoma, early metastasis is generally believed that surgical treatment should not be. It was also suggested that the young people for the early detection of primary lung cancer, radical surgical treatment should be adopted.
Small cell lung cancer chemotherapy
The main treatment of small cell lung cancer is chemotherapy, chemotherapy appears mostly after the start of treatment within 12 weeks, followed by very rare to see a further increase in efficacy. In general, the use of moderately enhanced chemotherapeutic effect of chemotherapy is better than conventional measures; but high-dose intensive therapy did not further improve efficacy, but so that more patients require hospitalization. On the limitations of small cell lung cancer the best treatment whether it should be combined with chemotherapy plus chest step in radiotherapy, there are still a different consciousness. With regard to chemotherapy - radiotherapy combined with treatment programs in the best time of radiotherapy, at present not been determined.
Studies have shown that the use of small-cell lung cancer chemotherapy drug to form a coalition and effective chemotherapy, the survival rate achieved in an efficient and superior to single-agent chemotherapy. In recent years, many units, the use of bronchial arteriography infusion chemotherapy for the treatment of small cell lung cancer drugs are generally reported good results, fewer side effects.
Small-cell lung cancer radiation therapy
Thanks to the simple treatment of small cell lung cancer with chemotherapy chest high rate of local recurrence, it advocated during chemotherapy, combined with chest radiotherapy primary tumor in order to improve intrathoracic tumor local control rate.
Radiotherapy range: primary tumor and lymphatic metastasis has been, and includes a broader nearby lymphatic drainage area; in recent years, has also been suggested to narrow the scope of exposure, only induction chemotherapy before radiation clinical imaging diagnosis of a tumor can be found.
Radiation dose: is generally believed that the clinical tumor of 45-55Gy, sub-clinical lesions of 35-40 Gy ,1.8-2 .0 Gy / times, 5 times a week exposure.
When the interval of chemotherapy and radiation therapy when used in radiotherapy placed in two courses of chemotherapy before and after the rest period of time, based on the length of rest time can be divided into the total tumor volume for each course of 15-20 Gy, a total of 3 courses, or 25 -30 Gy, a total of 2 course of treatment.
Stem cell transplantation with chemotherapy for small cell lung cancer
Their own peripheral blood stem cell transplantation for the aid of high-dose chemotherapy has been widely carried out. The methods were: First, use of conventional chemotherapy and acquired lesions were reduced, the mobilization of peripheral blood stem cells in blood cell sorter to take peripheral blood stem cells, and then high-dose chemotherapy CVpP program, 24-48 hours after chemotherapy, stem-cell reinfusion.
Small-cell lung cancer immunotherapy
It has been reported that the thymus factor on the treatment of pulmonary oat cell carcinoma has a good effect; interferon can improve the immune function of patients with lung cancer.